Andrew T. Bender

Andrew T. Bender

Auto-generated profile, based on publicly available information

Andrew T. Bender

Department of Mechanical Engineering, University of Washington, Stevens Way, Box 352600, Seattle, Washington, 98195, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2018 in Analytical Chemistry
Verified
Journal Article
Closed access
ABAndrew T. Bender
Andrew T. Bender
MBMark D. Borysiak
Mark D. Borysiak
ALAmanda M. Levenson
Amanda M. Levenson
LLLorraine Lillis
Lorraine Lillis
DBDavid S. Boyle
David S. Boyle
JPJonathan D. Posner
Jonathan D. Posner

23 March 2021 in The Analyst
Verified
Journal Article
Closed access
PDF file
JZJane Y. Zhang
Jane Y. Zhang
ABAndrew T. Bender
Andrew T. Bender
DBDavid S. Boyle
David S. Boyle
PDPaul K. Drain
Paul K. Drain
JPJonathan D. Posner
Jonathan D. Posner
The COVID-19 pandemic has put the spotlight on the urgent need for point-of-care nucleic acid tests (NATs) for infectious diseases.

6 April 2021 in The Analyst
Verified
Journal Article
Closed access
PDF file
ABAndrew T. Bender
Andrew T. Bender
BSBenjamin P. Sullivan
Benjamin P. Sullivan
JZJane Y. Zhang
Jane Y. Zhang
DJDavid C. Juergens
David C. Juergens
LLLorraine Lillis
Lorraine Lillis
JPJonathan D. Posner
Jonathan D. Posner
An HIV detection assay featuring a low-cost μPAD for electrophoretic RNA extraction and rapid isothermal nucleic acid amplification.

25 October 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CCCatherine T. Chia
Catherine T. Chia
ABAndrew T. Bender
Andrew T. Bender
LLLorraine Lillis
Lorraine Lillis
BSBenjamin P. Sullivan
Benjamin P. Sullivan
CMColeman D. Martin
Coleman D. Martin
JPJonathan D. Posner
Jonathan D. Posner
Over 71 million people are infected with hepatitis C virus (HCV) worldwide, and approximately 400,000 global deaths result from complications of untreated chronic HCV. Pan-genomic direct-acting antivirals (DAAs) have recently become widely available and feature high cure rates in less than 12 weeks of treatment. The rollout of DAAs is reliant on diagnostic tests for HCV RNA to identify eligible patients with viremic HCV infections. Current PCR-based HCV RNA assays are restricted to well-resourced central laboratories, and there remains a prevailing clinical need for expanded access to decentralized HCV RNA testing to provide rapid chronic HCV diagnosis and linkage to DAAs in outpatient clinics. This paper reports a rapid, highly accurate, and minimally instrumented assay for HCV RNA detection using reverse transcription recombinase polymerase amplification (RT-RPA). The assay detects all HCV genotypes with a limit of detection of 25 copies per reaction for genotype 1, the most prevalent in the United States and worldwide. The clinical sensitivity and specificity of the RT-RPA assay were both 100% when evaluated using 78 diverse clinical serum specimens. The accuracy, short runtime, and low heating demands of RT-RPA may enable implementation in a point-of-care HCV test to expand global access to effective treatment via rapid chronic HCV diagnosis.

14 June 2022 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
BSBenjamin P. Sullivan
Benjamin P. Sullivan
YCYu-Shan Chou
Yu-Shan Chou
ABAndrew T. Bender
Andrew T. Bender
CMColeman D. Martin
Coleman D. Martin
ZKZoe G. Kaputa
Zoe G. Kaputa
JPJonathan D. Posner
Jonathan D. Posner
We report a novel method for the quantification of isothermal amplification reactions on paper membranes using discrete fluorescent amplification nucleation sites.

6 April 2020 in ACS Sensors
Verified
Journal Article
Closed access
AOAyokunle Olanrewaju
Ayokunle Olanrewaju
BSBenjamin P. Sullivan
Benjamin P. Sullivan
JZJane Y. Zhang
Jane Y. Zhang
ABAndrew T. Bender
Andrew T. Bender
DSDerin Sevenler
Derin Sevenler
JPJonathan D. Posner
Jonathan D. Posner